Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...

Vercel has released Next.js 16.2, featuring performance enhancements that make development startup 400% faster and rendering ...

A Bugcrowd researcher has unveiled ExploitBench, an independent benchmark of AI models for vulnerability exploitation ...

Whether it’s creating a strategy for current and future tech needs or deploying a new cybersecurity platform to protect company data, these IT consulting firms in and around Chicago are helping ...

It’s not just you. It really is getting harder to outpace the other guys. Our recent research finds that since the middle of the 1990s, which marked the mainstream adoption of the internet and ...

A two-part adaptation of Stephen King's iconic novel of the same name. Seven children in Derry, Maine are terrorized by an eponymous being, only to face their own personal demons in the process. This ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...

Many adults are sharing device data with providers too. But users are typically healthier and wealthier, suggesting people who could benefit the most from health monitoring are less likely to adopt ...

A broader set of evaluation goals will boost agility and capacity to manage artificial intelligence projects in healthcare and elsewhere, said NIST leaders – aligning capability evaluations, ...